AstraZeneca recalls Corona vaccine from markets around the world
The pharmaceutical company says that due to the abundance of vaccine available for Corona, they decided to withdraw it. AstraZeneca said that an updated vaccine is being deployed, which is capable of dealing with the new variant.
After the worldwide uproar over the side effects of British pharmaceutical company AstraZeneca's Corona Vaccine, the company has taken the initiative to withdraw its Corona vaccine globally. The British pharmaceutical company had admitted that their Covishield vaccine could have rare side effects. The pharma company has admitted that their Covishield vaccine can also cause blood clotting and low platelet count in many rare cases. The vaccine made by Serum Institute in India named Covishield is the same formula of AstraZeneca.
According to the report, the vaccine manufacturing company argues that its withdrawal was started worldwide due to commercial reasons. The pharmaceutical company says that due to the abundance of vaccine available for Corona, they decided to withdraw it. AstraZeneca said that an updated vaccine is being deployed, which is capable of dealing with the new variant.
AstraZeneca voluntarily withdrew its "marketing authorization" in the European Union. He said that the vaccine is no longer being produced and can no longer be used. Similarly, the vaccine will also be withdrawn from other countries using it.
AstraZeneca is facing a 100 million pound lawsuit in the UK after it admitted that its vaccine had caused many deaths and many others illness. In a case related to a 100 million pound class action lawsuit against the pharmaceutical company in a British court, the company admitted that the vaccine can actually cause thrombosis thrombocytopenia syndrome (TTS) in rare cases.
“According to independent estimates, in just the first year of use, more than 6.5 million lives were saved and more than three billion doses were supplied globally,” AstraZeneca said in a statement. Our efforts have been recognized by governments around the world and the vaccine is widely recognized as a critical component of ending the global pandemic. Because many types of corona vaccines have been developed, there is an abundance of vaccines available. "We will now work with regulators and our partners to move forward on a clear path to making a significant contribution to the COVID-19 pandemic with an updated vaccine."